Prevention and treatment of Mycobacterium avium complex infection.
Mangura
B T
BT
University of Medicine and Dentistry of New Jersey, New Jersey Medical School-National Tuberculosis Center, Department of Medicine, University Hospital, Newark 07102.
Reichman
L B
LB
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004347:Drug Interactions; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D017828:Rifabutin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D017828:Rifabutin